Intellectual Property India Publishes Patent Application for 'A System, A Method And A Hybrid Scaffold Platform For Ai-Designed Quinazolinone-racetam Derivatives As Multi-Target Therapeutics For Drug-Resistant Epilepsy' Filed by Swami Vivekananda Subharti University

MUMBAI, India, March 13 -- Intellectual Property India has published a patent application (202611009517 A) filed by Swami Vivekananda Subharti University, Meerut, Uttar Pradesh, on Jan. 30, for 'a system, a method and a hybrid scaffold platform for ai-designed quinazolinone-racetam derivatives as multi-target therapeutics for drug-resistant epilepsy.'

Inventor(s) include Dr. Nidhi Dhama; and Dr. Aadesh Kumar.

The application for the patent was published on March 13, under issue no. 11/2026.

According to the abstract released by the Intellectual Property India: "The present invention discloses AI-designed quinazolinone-racetam hybrid scaffolds engineered as next-generation multi-target therapeutics for drug-resistant epilepsy. The inventi...